Charles Lee Nuzum's most recent trade in Predictive Oncology Inc was a trade of 3,268 Common Stock done . Disclosure was reported to the exchange on April 5, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Predictive Oncology Inc | Charles Lee Nuzum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2024 | 3,268 | 31,921 (0%) | 0% | 0 | Common Stock | |
| Predictive Oncology Inc | Charles Lee Nuzum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 3,773 | 34,033 (0%) | 0% | 0 | Common Stock | |
| Predictive Oncology Inc | Charles Lee Nuzum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 25,499 | 605,203 (14%) | 0% | 0 | Common Stock | |
| Predictive Oncology Inc | Charles Lee Nuzum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 53,539 | 579,704 (14%) | 1% | 0 | Common Stock | |
| Predictive Oncology Inc | Charles Lee Nuzum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 172,150 | 526,165 (13%) | 4% | 0 | Common Stock | |
| Predictive Oncology Inc | Charles Lee Nuzum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 23,147 | 354,015 (8%) | 0% | 0 | Common Stock | |
| Predictive Oncology Inc | Charles Lee Nuzum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 44,704 | 330,868 (8%) | 1% | 0 | Common Stock | |
| Predictive Oncology Inc | Charles Lee Nuzum | Director | Purchase of securities on an exchange or from another person at price $ 0.31 per share. | 20 May 2022 | 200,000 | 286,164 (7%) | 4% | 0.3 | 62,320 | Common Stock |
| Predictive Oncology Inc | Charles Lee Nuzum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 8,530 | 86,164 (2%) | 0% | 0 | Common Stock | |
| Predictive Oncology Inc | Charles Lee Nuzum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 43,775 | 77,634 (1%) | 1% | 0 | Common Stock | |
| Predictive Oncology Inc | Charles Lee Nuzum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 6,265 | 33,859 (0%) | 0% | 0 | Common Stock | |
| Predictive Oncology Inc | Charles Lee Nuzum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 13,995 | 27,594 (0%) | 0% | 0 | Common Stock | |
| Predictive Oncology Inc | Charles Lee Nuzum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 6,887 | 13,599 (0%) | 0% | 0 | Common Stock | |
| Predictive Oncology Inc | Charles Lee Nuzum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 6,142 | 6,142 | - | - | Stock Options (right to buy) |